zintick

Eikon Therapeutics EIKN

Eikon Therapeutics, Inc. · Nasdaq · Biological Products, (No Diagnostic Substances)

$5.54-0.18%close on Oct. 28, 2026 · volume 660K · Yahoo Finance

Price, last 47 sessions

$6.00$8.00$10.00$12.00Sept. 2026Oct. 2026
Aug. 24, 2026 to Oct. 28, 2026 · high $12.55 · low $5.54 · SEC filing, placed when SEC released it

Our coverage

Nothing published yet.

Insider buying and selling

DateInsiderTradeSharesAvg. priceValue
Sept. 3, 2026Column Group IV GP LP
with Column Group IV-A LP, Column Group IV LP, Column Group Opportunity III LP, Column Group Opportunity III GP LP, TCG Opportunity III GP LLC, Tim Kutzkey, Peter Svennilson
10% owner · indirect
Bought89,200$11.56$1.03 million

Open-market purchases and sales reported on SEC Form 4 filed since July 24, 2026; grants, option exercises and shares withheld for tax aren't shown. A trade under a 10b5-1 plan was scheduled in advance. Where a filing was amended, the amendment's figures are shown.

Recent SEC filings

All 10 →
  • 8-KOct. 26, 2026, 6 a.m. ETView on SEC.gov

    Regulation FD disclosure · Other events · Financial statements and exhibits

    AI summary, unreviewedEikon Therapeutics Reports 63.1% Objective Response Rate for EIK1001 in First-Line NSCLC at ESMO 2026, Squamous Cohort 72.4%

  • 8-KOct. 23, 2026, 9:15 a.m. ETView on SEC.gov

    Regulation FD disclosure · Other events · Financial statements and exhibits

    AI summary, unreviewedEikon Therapeutics Presents Mixed Early Clinical Data for EIK1003, EIK1004 and EIK1005 at ESMO 2026, With Modest Response Rates

  • SCHEDULE 13G/AOct. 7, 2026, 11:47 a.m. ETView on SEC.gov
  • SCHEDULE 13G/AOct. 2, 2026, 11:14 a.m. ETView on SEC.gov
  • 4Sept. 8, 2026, 4:33 p.m. ETView on SEC.gov
  • 8-KAug. 13, 2026, 8:44 p.m. ETView on SEC.gov

    Regulation FD disclosure · Financial statements and exhibits

  • 10-QAug. 13, 2026, 4:10 p.m. ETView on SEC.gov
  • 8-KAug. 13, 2026, 4:06 p.m. ETView on SEC.gov

    Results of operations and financial condition · Financial statements and exhibits